Assignee
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD
CN·3 granted patents·2 pending applications·0 citations·filing 2015–2021
Top patents by PatentIndex Score
5 records- 0147US2024085383A1Method for detecting content of glycosaminoglycan carboxylated derivative in sample, and application thereofSHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0241US11225531B2Glycosaminoglycan derivative and preparation method therefor and use thereofSHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jan 18, 2022·0 cites·17 claims
- 0336US2019002596A1Sulfated heparin oligosaccharide and preparation method and application thereofSHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD·Filed 2015·Application pending·0 cites
- 0435US10900028B2Heparinase-producing Pseudomonas stutzeri strain and heparinase derived therefromSHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·18 claims
- 0522US10214735B2Heparinases obtained from Sphingobacterium daejeonense, preparation therefor and application thereofSHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Feb 26, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →